CONNECT WITH US
HealthTech

HealthTech

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range

Medical Xpress logo

Published on

Add as a preferred source on Google
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine.

The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

CGMs use a small sensor worn on the body to continuously track glucose levels throughout the day and night. This allows patients to see how their blood sugar responds to food, physical activity and other daily habits, potentially helping them make more informed decisions about managing their diabetes.

"An estimated 20 million adults in the United States have type 2 diabetes and do not take insulin, and despite advances in treatment, many still do not reach glycemic targets," said first author Tamara Oser, M.D., a professor in the University of Colorado Anschutz Department of Family Medicine.

"Over time, elevated blood sugar can increase the risk of serious health complications, including heart disease, kidney disease and vision loss, so it's important we continue to improve care for everyone with diabetes."

Oser and her co-authors also found that CGM users experienced significantly greater improvements in A1c, a measure of average blood sugar over approximately three months.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.